Inicia sesión Registrate Mi Biblioteca idioma

Idioma

biblioteca idioma abrir menu

Bibliografía Científica

Artículos por temáticas

En este apartado encontrará la selección de artículos sobre Trastornos del Movimiento clasificados según los 11 tipos establecidos por International Parkinson & Movement Disorder Society.

Corea y enfermedad de Huntington

5163 ARTíCULOS , VIENDO DEL 5071 AL 5085

PUBMED

[Antiphospolipid syndrome related chorea gravidarum case with psychotic symptoms misdiagnosed as conversion disorder: case report].

Kuz Tekşut T, Özcan H, Işık M, Karslı F.

Turk Psikiyatri Derg. 2013 Winter;24(4):280-3. Turkish.

0

0

0

PUBMED

The role of the striatum in linguistic selection: Evidence from Huntington's disease and computational modeling.

Giavazzi M, Daland R, Palminteri S, Peperkamp S, Brugières P, Jacquemot C, Schramm C, Cleret de Langavant L, Bachoud-Lévi AC.

Cortex. 2018 Dec;109:189-204. doi: 10.1016/j.cortex.2018.08.031. Epub 2018 Sep 15.

0

0

0

PUBMED

A 60-year-old woman with chorea and weight loss.

Vick A, Kraemer RR, Morris JL, Willett LL, Centor RM, Estrada CA, Rodriguez JM.

J Gen Intern Med. 2012 Jun;27(6):747-51. doi: 10.1007/s11606-011-1928-x. No abstract available.

0

0

0

PUBMED

Biological and clinical changes in premanifest and early stage Huntington's disease in the TRACK-HD study: the 12-month longitudinal analysis.

Tabrizi SJ, Scahill RI, Durr A, Roos RA, Leavitt BR, Jones R, Landwehrmeyer GB, Fox NC, Johnson H, Hicks SL, Kennard C, Craufurd D, Frost C, Langbehn DR, Reilmann R, Stout JC; TRACK-HD Investigators..

Lancet Neurol. 2011 Jan;10(1):31-42. doi: 10.1016/S1474-4422(10)70276-3.

0

0

0

PUBMED

A New VMAT-2 Inhibitor NBI-641449 in the Treatment of Huntington Disease.

Chen S, Zhang XJ, Xie WJ, Qiu HY, Liu H, Le WD.

CNS Neurosci Ther. 2015 Aug;21(8):662-71. doi: 10.1111/cns.12425.

0

0

0

PUBMED

The interplay between redox signalling and proteostasis in neurodegeneration: In vivo effects of a mitochondria-targeted antioxidant in Huntington's disease mice.

Pinho BR, Duarte AI, Canas PM, Moreira PI, Murphy MP, Oliveira JMA.

Free Radic Biol Med. 2020 Jan;146:372-382. doi: 10.1016/j.freeradbiomed.2019.11.021. Epub 2019 Nov 18.

0

0

0

PUBMED

Dopamine receptor autoantibodies correlate with symptoms in Sydenham's chorea.

Ben-Pazi H, Stoner JA, Cunningham MW.

PLoS One. 2013 Sep 20;8(9):e73516. doi: 10.1371/journal.pone.0073516.

0

0

0

PUBMED

Specific promoter deacetylation of histone H3 is conserved across mouse models of Huntington's disease in the absence of bulk changes.

Guiretti D, Sempere A, Lopez-Atalaya JP, Ferrer-Montiel A, Barco A, Valor LM.

Neurobiol Dis. 2016 May;89:190-201. doi: 10.1016/j.nbd.2016.02.004.

0

0

0

PUBMED

Inhibiting pathologically active ADAM10 rescues synaptic and cognitive decline in Huntington's disease.

Vezzoli E, Caron I, Talpo F, Besusso D, Conforti P, Battaglia E, Sogne E, Falqui A, Petricca L, Verani M, Martufi P, Caricasole A, Bresciani A, Cecchetti O, Rivetti di Val Cervo P, Sancini G, Riess O,

J Clin Invest. 2019 May 6;130. pii: 120616. doi: 10.1172/JCI120616. eCollection 2019 May 6.

0

0

0

PUBMED

Stability of resting fMRI interregional correlations analyzed in subject-native space: a one-year longitudinal study in healthy adults and premanifest Huntington's disease.

Seibert TM, Majid DS, Aron AR, Corey-Bloom J, Brewer JB.

Neuroimage. 2012 Feb 1;59(3):2452-63. doi: 10.1016/j.neuroimage.2011.08.105.

0

0

0

PUBMED

First use of creatine hydrochloride in premanifest Huntington disease.

Tuckfield C.

Med J Aust. 2015 Apr 20;202(7):378-80. No abstract available.

0

0

0

PUBMED

A treatable new cause of chorea: beta-ketothiolase deficiency.

Buhaş D, Bernard G, Fukao T, Décarie JC, Chouinard S, Mitchell GA.

Mov Disord. 2013 Jul;28(8):1054-6. doi: 10.1002/mds.25538. No abstract available.

0

0

0

PUBMED

Is mitochondrial oxidative metabolism the right therapy target in early Huntington disease?

Lodi R.

Neurology. 2017 Jan 10;88(2):116-117. doi: 10.1212/WNL.0000000000003497. No abstract available.

0

0

0

PUBMED

Progerin-Induced Transcriptional Changes in Huntington's Disease Human Pluripotent Stem Cell-Derived Neurons.

Cohen-Carmon D, Sorek M, Lerner V, Nissim-Rafinia M, Yarom Y, Meshorer E.

Mol Neurobiol. 2019 Dec 13. doi: 10.1007/s12035-019-01839-8. [Epub ahead of print]

0

0

0

PUBMED

Decreased striatal RGS2 expression is neuroprotective in Huntington's disease (HD) and exemplifies a compensatory aspect of HD-induced gene regulation.

Seredenina T, Gokce O, Luthi-Carter R.

PLoS One. 2011;6(7):e22231. doi: 10.1371/journal.pone.0022231.

0

0

0

Comentarios

En ningún caso la información facilitada constituye asesoramiento por parte de Zambon

Con el aval de:

Logo SEN Logo HONcode Logo WIS

En colaboración con:

Zambon Neuroacademy